logo

Bristol-Myers Squibb Co. (BMY)



Trade BMY now with
  Date
  Headline
12/10/2018 2:02:21 AM Bristol-Myers,Vedanta Announce Collaboration To Evaluate OPDIVO , VE800 In Patients With Advanced Or Metastatic Cancers
12/6/2018 4:18:04 PM Bristol-Myers Squibb Co. (BMY) Declares Quarterly Dividend of $ 0.41, Record Date 1/4/2019
12/6/2018 4:16:46 PM Bristol-Myers Squibb Declares Quarterly Dividend Of $0.41, Payable Feb. 1/ Record Jan. 4
11/27/2018 7:15:14 AM William Blair Reiterates Bristol-Myers Squibb Co. (BMY) At Outperform
11/15/2018 4:32:30 PM Bristol-Myers Gets Positive CHMP Opinion Recommending Approval Of Opdivo Plus Low-Dose Yervoy
11/6/2018 4:35:39 PM Bristol-Myers Squibb: FDA Approves Empliciti Plus Pomalidomide And Dexamethasone
11/5/2018 7:01:52 AM Bristol-Myers, Infinity Collaborate To Evaluate Opdivo In Combination With IPI-549 In Urothelial Cancer
10/25/2018 8:08:07 AM Halozyme Reports First Clinical Dosing In Bristol-Myers Squibb's Phase 1 Trial Of BMS-986179 With Enhanze Technology
10/25/2018 7:54:05 AM Bristol-Myers Squibb Co. (BMY) Has Raised Its FY18 EPS Estimate To 3.80 - 3.90 From 3.55 - 3.65
10/25/2018 7:00:18 AM Bristol-Myers Squibb Posts Q3 GAAP EPS Of $1.16 And Non-GAAP EPS Of $1.09
10/22/2018 7:19:08 AM William Blair Reiterates Bristol-Myers Squibb Co. (BMY) At Outperform
10/22/2018 3:37:49 AM Bristol-Myers Squibb Announces New Data From Cohort Of CheckMate -142 Study
10/22/2018 3:34:43 AM Bristol-Myers Squibb Announces Four-year Data From Phase 3 CheckMate -067 Clinical Trial